This bill recognizes the service of individuals who were members of the U.S. Cadet Nurse Corps between July 1, 1943, and December 31, 1948, by treating that service as active duty for specific burial-related benefits. It requires the Secretary of Defense to issue an honorable discharge to eligible individuals within one year of the bill's enactment, designating their discharge date. The bill allows for commemorative items like service medals or plaques but clarifies that recipients will not receive most VA benefits (only headstones/markers under specific chapters of law). It directly affects living cadet nurses from that era and their families for burial purposes.
This bill directs the American Battle Monuments Commission to correct historical errors by identifying Jewish World War I and II veterans buried overseas under incorrect Christian markers (Latin crosses) and replacing them with appropriate markers. It establishes a 10-year program to contact families of affected veterans, with the Commission funding the effort at $500,000 annually through nonprofit contracts. The program specifically targets veterans buried in foreign U.S. military cemeteries with markers indicating non-Jewish faith, addressing a documented mistake affecting approximately 900 Jewish servicemembers. This directly affects Jewish veterans' families by honoring their heritage and correcting past burial inaccuracies.
SRES 536 is a non-binding Senate resolution designating December 2, 2025, as "World Nuclear Energy Day." It commemorates nuclear energy's role in clean power generation, highlighting historical milestones like the first nuclear chain reaction (1942) and the first commercial nuclear plant (1957). The resolution celebrates nuclear energy's contributions to U.S. electricity (18% of generation, 43% carbon-free), job creation (over 70,000 direct jobs), and national security, without creating new laws or affecting any group. It serves as a symbolic recognition of the industry's achievements.
This bill removes barriers for people with past drug-related convictions to access federal assistance programs. It amends welfare law to allow states to provide Temporary Assistance for Needy Families (TANF) benefits to individuals with such convictions and prohibits states from denying Supplemental Nutrition Assistance Program (SNAP) benefits based on drug convictions. The bill also adds "incarcerated individuals scheduled for release within 30 days" to SNAP household eligibility criteria. These changes directly affect individuals with past drug convictions seeking welfare or food assistance, removing state-level restrictions that previously barred them.
The PBM Price Transparency and Accountability Act requires pharmacy benefit managers (PBMs) to be more transparent about drug pricing and ensure accurate payments to pharmacies. It establishes national average drug acquisition cost benchmarks for Medicaid, prohibits PBMs from keeping excessive profits through "spread pricing," and mandates detailed reporting of drug pricing, rebates, and fees. The bill affects Medicaid programs, Medicare Part D plans, and the PBMs that negotiate drug prices on behalf of insurers. It includes enforcement mechanisms like civil penalties for non-compliance and requires PBMs to report detailed pricing information to the Secretary of Health and Human Services.
The HUSTLE Act creates tax-advantaged investment accounts for student athletes to save income from name, image, and likeness (NIL) deals. Eligible student athletes at participating colleges can contribute NIL earnings (like endorsements and social media content) to these accounts, which are tax-exempt for the athlete. Distributions before graduation are taxed as ordinary income, but distributions after graduation or transfer qualify for lower long-term capital gains tax rates. The accounts have annual contribution limits based on the gift tax exclusion and require management by banks or approved entities. The bill also includes new rules for sports agents, such as a 5% fee cap on endorsement contracts and registration requirements.
The Cargo Security Innovation Act establishes a pilot program to test advanced security technologies at up to six high-risk cargo transportation hubs, such as ports, airports, and rail yards, with elevated cargo theft rates. The Transportation Security Administration will provide grants to partnerships between transportation companies, rail police, and local law enforcement to deploy and evaluate these technologies. The bill prohibits using technology from "foreign entities of concern" and requires grantees to track fund usage for audits. After two years, the TSA must report on the technologies' effectiveness, and the pilot will end three years after initial deployment, followed by a GAO evaluation.
The Back the Blue Act of 2025 creates new federal criminal offenses for killing or assaulting law enforcement officers, judges, and certain public safety personnel (including firefighters and first responders) while they are on duty or because of their official status. It increases penalties for these crimes, including minimum 10-year prison terms for killing officers and longer sentences for assaults causing serious injury, with the death penalty possible for killings. The bill also adds a "flight to avoid prosecution" provision for those fleeing to evade charges for killing officers, expands law enforcement officers' rights to carry firearms in certain circumstances, and limits federal habeas corpus relief for individuals convicted of killing law enforcement officers. This legislation directly affects law enforcement officers, judges, and public safety personnel, as well as individuals who commit violence against them.
HR 6466, the Forced Abortion Prevention and Accountability Act, prohibits non-consensual administration of abortion drugs (like mifepristone or misoprostol) to pregnant women without their informed consent. It criminalizes this act with penalties up to 25 years in prison and allows victims to sue for triple damages, psychological/physical injury compensation, and attorney fees. The bill directly affects pregnant women who might face coerced procedures and medical providers or others who administer such drugs without consent. Key provisions include criminal penalties for the act itself, enhanced penalties for serious injury or death, and a civil remedy framework for victims seeking compensation.
This bill imposes a 20% tax on certain loans secured by assets like stocks or business property for individuals earning over $400,000 annually (or $450,000 for joint returns). The tax applies to the borrowed amount each year and is paid directly by borrowers. It specifically excludes home mortgages, home equity loans, margin loans, and farmland-secured loans. The tax targets high-value lending outside standard residential financing, with new rules taking effect after the bill's enactment.
HR 6449, the "DO NOT Call Act," amends the Telephone Consumer Protection Act of 1993 to strengthen penalties for illegal robocalls. It increases criminal penalties for willful violations to up to one year in prison (or three years for aggravated offenses like repeated high-volume calls or calls intended to support felonies), and raises fines for inaccurate caller identification from $10,000 to $20,000 per violation. The bill directly affects businesses and entities making unsolicited calls without consent, including those using auto-dialers or prerecorded messages. Key provisions define "calls" broadly to include unsolicited texts sent via auto-dialers without prior permission.
The Freedom to Heal Act of 2025 creates a new federal registration process for physicians to directly administer Schedule I investigational drugs under the "Right to Try" framework. It requires physicians to apply to the Attorney General with evidence of state compliance, manufacturer agreements, and training, and limits the amount of drugs they may possess based on approved applications. The bill mandates the Attorney General to issue interim rules within 240 days and final rules within two years covering drug delivery, storage, recordkeeping, and registration management. This affects physicians treating eligible patients with Schedule I drugs under federal Right to Try provisions, not the patients themselves.
